Unbound MEDLINE

The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis. Pathophysiology of haemostasis and thrombosis. [Pathophysiol Haemost Thromb] Journal article

 
TitleThe influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
Author(s)Sabovic M, Salobir B, Preloznik Zupan I, Bratina P, Bojec V, Buturovic Ponikvar J 
InstitutionDepartment of Vascular Diseases, University Clinical Centre, Ljubljana, Slovenia.
SourcePathophysiol Haemost Thromb 2005; 34(6):274-8.
AbstractIn end-stage renal disease, in particularly when treated with haemodialysis, the function of platelets, coagulation and fibrinolytic systems can be disturbed, thus contributing to either thrombotic or bleeding complications. It is important to know whether the currently used haemodialysis procedure itself (by biocompatible membranes and better anticoagulation with nandroparin) affects platelets, coagulation or fibrinolysis. In 15 patients who had been treated with chronic haemodialysis, we measured and compared platelet aggregation (induced by adenosine diphosphate, collagen and epinephrine), the markers of coagulation and fibrinolysis activation (thrombin-antithrombin complexes, thrombin fragments F1+2, D-dimer), and fibrinolytic parameters, i.e. fibrinogen, plasminogen, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 antigen and activity, before and immediately after the regular haemodialysis sessions. We did not find differences between pre- and post-haemodialysis platelet aggregation induced with all agents. Markers of coagulation and fibrinolysis activation remained unchanged during the process of haemodialysis. However, in post-haemodialysis samples, t-PA activity was significantly increased. Other fibrinolytic parameters remained unchanged. In conclusion, our results showed that the current technique of haemodialysis procedure does not affect platelet aggregation or activate coagulation, and therefore, does not contribute to a thrombotic tendency. However, it does directly affect fibrinolysis through activation of t-PA, which might be clinically relevant since this could increase the bleeding tendency in some haemodialysis patients. Copyright (c) 2005 S. Karger AG, Basel.
Languageeng
Pub Type(s)Journal Article
PubMed ID16772739
  
Advertise on this site.